These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20375658)

  • 1. Oxcarbazepine for the treatment of trichotillomania.
    Leombruni P; Gastaldi F
    Clin Neuropharmacol; 2010; 33(2):107-8. PubMed ID: 20375658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine for the treatment of binge eating disorder: a case series.
    Leombruni P; Gastaldi F; Lavagnino L; Fassino S
    Adv Ther; 2008 Jul; 25(7):718-24. PubMed ID: 18636233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
    Hirschfeld RM; Kasper S
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):507-22. PubMed ID: 15458610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder.
    Malek-Ahmadi P; Hanretta AT
    Ann Pharmacother; 2004 Nov; 38(11):1852-4. PubMed ID: 15479776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine in a carbamazepine-intolerant patient with bipolar affective disorder: a case report.
    Kalra H; Dalal PK; Allet L; Janca A
    Psychiatr Danub; 2006 Jun; 18(1-2):90-1. PubMed ID: 16804505
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode.
    Benedetti A; Lattanzi L; Pini S; Musetti L; Dell'Osso L; Cassano GB
    J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine-related neutropenia: a case report.
    Hsiao YT; Wei IH; Huang CC
    J Clin Psychopharmacol; 2010 Feb; 30(1):94-5. PubMed ID: 20075666
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxcarbazepine in rapid benzodiazepine detoxification.
    Croissant B; Grosshans M; Diehl A; Mann K
    Am J Drug Alcohol Abuse; 2008; 34(5):534-40. PubMed ID: 18821451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder.
    Davids E; Kis B; Specka M; Gastpar M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1033-8. PubMed ID: 16698160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer anticonvulsants in the treatment of bipolar disorder.
    Yatham LN
    J Clin Psychiatry; 2004; 65 Suppl 10():28-35. PubMed ID: 15242330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience.
    Sachdeo R; Sathyan RR
    Curr Med Res Opin; 2005 Jul; 21(7):1065-8. PubMed ID: 16004674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine in the treatment of borderline personality disorder: a pilot study.
    Bellino S; Paradiso E; Bogetto F
    J Clin Psychiatry; 2005 Sep; 66(9):1111-5. PubMed ID: 16187767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
    Evins AE
    J Clin Psychiatry; 2003; 64 Suppl 8():9-14. PubMed ID: 12892536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scheme-based benzodiazepine detoxification with oxcarbazepine -- a case report.
    Croissant B; Grosshans M; Klein O; Diehl A; Mann K
    Pharmacopsychiatry; 2005 Sep; 38(5):222-3. PubMed ID: 16189750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.
    Aigner M; Treasure J; Kaye W; Kasper S;
    World J Biol Psychiatry; 2011 Sep; 12(6):400-43. PubMed ID: 21961502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin.
    Criscuolo S; Auletta C; Lippi S; Brogi F; Brogi A
    Acta Neurol Scand; 2005 Apr; 111(4):229-32. PubMed ID: 15740573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manic espisode, confusional syndrome and reversible splenial lesion after abrupt withdrawal of oxcarbazepine.
    Merizalde M; Navalón P; González MF; Domínguez A; Livianos L; Martínez JC
    J Affect Disord; 2017 Mar; 210():122-124. PubMed ID: 28027511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.